Ribociclib Succinate | m-entrepreneurship.com

Product Name :
Ribociclib Succinate

Search keywords :
Ribociclib

drugId :
null

Target Vo:
Cyclin-dependent kinase 6

Target Vo Short Name :
CDK6

Moa_Name:
Cyclin-dependent kinase 6 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Beijing Novartis Pharma Co Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SUMO1 Antibody (YA046)
Histone H4 Antibody
Histone H3 (acetyl K56) Antibody: Histone H3 (acetyl K56) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K56). It can be used for WB,ICC/IF,IHC-P,ChIP,CUT&Tag-seq assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts